PolyModels Hub has secured £1.1 million in seed funding to develop a software platform that will “build the digital backbone for pharma”. Marathon Venture Capital led the funding round, which will drive the London-based start-up’s mission to enable pharmaceutical companies to deliver breakthrough therapies faster. The development of complex therapeutic modalities has traditionally led to increasing research and development costs per molecule. However, PolyModels Hub introduced a digital platform known as ModelFlow, which integrates models, scientific data and insights into a single, effective product. The new platform will shift the focus to advancing companies’ drug portfolios through regulatory and business milestones by offering a robust project management solution that maximises digital tools.
According to co-founder and CEO Antonio Benedetti: “Developing a drug remains an expensive and time-consuming process. Our vision for PolyModels Hub is to revolutionise how scientists, digital teams and senior stakeholders collaborate to accelerate development efforts and bring breakthrough therapies to market faster than ever. With today’s advanced technology, supportive business context and favourable regulatory framework, we believe now is the perfect time to realise this vision”.
